WAT

Health Technology
$329.22 -1.20%
Back to Screener
Live Volume
856,359
Market Cap
32.32 B
P/E Ratio
41.91
52W Peak Proximity
%79

ANALYSIS CENTER

AI Rating & Analysis: WAT stock analysis with hallucination-free AI screener tools — real-time price, volume, P/E ratio, 52-week proximity and sector performance data for Health Technology. AI-powered stock analysis and research platform.
GOD-TIER PROMPT ACTIVE
Investment report at Goldman Sachs + Bridgewater + Renaissance Technologies level
10 sections: Tables • Charts • Bullet Points. Plain text PROHIBITED.
1Executive Summary
2Fair Value
3Fundamental Analysis
4Technical Analysis
5Scenario Analysis
6Competitor Comparison
7Dividend Return
8Risk Analysis
9Catalyst Calendar
10Action Plan
HOW IT WORKS: When you click an AI button below, this prompt is instantly copied to your clipboard. Simply Paste (CTRL+V) it into the chat box of the opened AI assistant to run the analysis.
İpucu: Tip: Use our TradingView charts for technical analysis. Evaluate alongside the AI report.
Open Advanced Chart
TradingView Charts
• 15-min delayed price feed • 100+ technical indicators • Sub-second updates • Professional drawing tools
Affiliate links — DocuRefinery may earn a commission when you open an account.

Interactive Brokers

SEC, FINRA, FCA, ASIC Regulation $0 Min. Deposit
Access 150+ global markets. Stocks, ETFs, Options, Futures, Forex.
Open Account

TD Ameritrade (Schwab)

SEC, FINRA Regulation $0 Min. Deposit
Industry-leading trading platforms and comprehensive education.
Open Account
All investing involves risk, including the possible loss of principal. Past performance does not guarantee future results.

Latest News — WAT

Waters Corporation — Company Profile & Analysis

Waters Corporation, founded in 1958 and headquartered in Milford, Massachusetts, stands as a global leader in the field of analytical science. The company's core mission is to provide innovative solutions that empower scientists and researchers to overcome complex analytical challenges. Since its inception, Waters has been dedicated to developing precise and reliable analytical instruments, aiming to accelerate scientific discovery and improve the quality of life. This vision has consistently driven the company to push technological boundaries and meet the most pressing needs of its customers. By contributing to the advancement of the scientific community, Waters plays a crucial role in creating a healthier, safer, and more sustainable world.

The company operates through two primary segments: Waters and TA. The Waters segment encompasses the design, manufacture, sale, and service of liquid chromatography and mass spectrometry (MS) technology systems. These systems are critical in areas such as drug discovery and development, clinical trial testing, the analysis of proteins in disease processes, nutritional safety analysis, and environmental testing. It also offers supporting products, including chromatography columns and other consumables. The TA segment designs, manufactures, sells, and services thermal analysis, rheometry, and calorimetry instruments. These instruments are used to predict the suitability and stability of fine chemicals, pharmaceuticals, water, polymers, metals, and viscous liquids, finding applications in various industrial, consumer goods, and healthcare products, as well as in life science research. Waters also develops and supplies software-based products that interface with its instruments, as well as those from other manufacturers.

Waters Corporation boasts a global reach, serving customers across Asia, the Americas, and Europe. Its products and solutions are utilized by clinical, pharmaceutical, biochemical, industrial, nutritional safety, environmental, academic, and governmental customers in research and development, quality assurance, and other laboratory applications. The company holds a strong position, particularly in the pharmaceutical, biotechnology, food safety, and environmental analysis markets. Its customer base spans a wide spectrum, from cutting-edge scientific research to routine quality control testing. This broad clientele and deep expertise across diverse sectors make Waters an indispensable player in the analytical science market.

Looking ahead, Waters Corporation aims to maintain its leadership in analytical technologies and drive growth through innovation. The company is focusing on emerging needs in fields such as life sciences, drug development, and advanced materials science. By integrating new technologies like artificial intelligence and machine learning into its analytical platforms, it seeks to make data analysis more efficient and predictive. Furthermore, it will continue to develop solutions that address the growing global demands for sustainability and environmental monitoring. Its strategic direction involves consolidating market share by maintaining customer focus, increasing R&D investments, and expanding its portfolio through potential acquisitions.

Economic Moat Waters Corporation's primary competitive advantage lies in its deep technological expertise and proprietary product portfolio in chromatography and mass spectrometry. This establishes an indispensable standard of reliability and performance for customers, particularly in highly regulated sectors like pharmaceutical development and quality control. Furthermore, the company's extensive consumables and service network strengthens customer loyalty and creates an ecosystem that is difficult for competitors to replicate, providing a sustainable competitive edge.
CEO Dr. Udit Batra Ph.D.
Employees 16,000
Headquarters United States
Market Competitors
Smart Tags
#AnalyticalScience #Chromatography #MassSpectrometry #DrugDiscovery #LabTechnology #NASDAQ #ScientificInstruments

Market Insights & Investor Q&A — WAT

Frequently Asked Questions

How can I quickly assess the advanced liquidity ratio for the WAT stock?
DocuRefinery offers an instant AI prompt that pulls the latest liquidity metrics for WAT and presents a risk score. Using the ready-made template, you get verified data without any manual entry.
Is there a free, no signup tool to run a real‑time market volatility stress test on WAT?
Yes, the platform provides a no‑registration AI solution that monitors market swings and generates a stress‑test report for WAT instantly. One click delivers the results.
Can I simplify WAT’s complex annual reports with AI prompts to speed up my investment decision?
The ready AI prompt extracts key financial figures and trends from WAT’s annual filing, turning a dense document into a concise summary. This lets you focus on the essentials without digging through pages.

Deep Analysis

AI‑Powered Ready Solutions for Analyzing WAT Stock

When evaluating a single ticker like WAT, modern AI methods scan balance‑sheet items, calculate liquidity ratios on the fly, and run real‑time volatility stress tests. DocuRefinery’s instant AI prompts automate data collection and modeling, delivering results in seconds.

Traditional analysis often requires hours of manual spreadsheet work. With AI‑driven ready prompts, verified data is processed instantly, providing trend detection and risk assessment with a single command. Users benefit from free, no‑signup templates that produce “instant AI results” for faster decision‑making.

Through prompt engineering, investors can craft custom analysis flows that combine liquidity checks, volatility scenarios, and report summarization. This modular approach ensures “hallucination‑free” outputs and lets you tailor the analysis to your strategy without writing code.